Branden

AND DID !!!!!!

AOC: This is what drinking water in Georgia looks like after Meta began data center construction in the community.

Eli Lilly released retatrutide Phase 3 data yesterday. 28% weight loss in 80 weeks. The most powerful obesity drug that’s ever been tested. And today the cancer signal drops. 12,112 patients. Seven tumor types. GLP-1 users had half the lung cancer metastasis rate (10% vs 22%). Breast cancer: 43% cut. Colon cancer five-year mortality in a separate study: 15.5% vs 37.1%. Cancer joins a list that already includes heart disease (SELECT, 20% MACE reduction), kidney failure (FLOW, 24% slower decline), sleep apnea (SURMOUNT-OSA, FDA-approved), addiction (BMJ, 600K veterans, 18-25% reduction across substances), and liver disease (86% fat clearance). Tumors express GLP-1 receptors. Activate them and NF-kB drops, apoptosis rises. The drug isn’t just shrinking fat. It’s talking directly to the cancer. One drug class. Designed for blood sugar. The biology keeps finding uses the designers didn’t predict.

Yesterday, I was giving an intro talk to our dept's new PhD students. Technical things aside, my number 1 suggestion has remained the same over the years: Treat your PhD like a job. - Avoid 1.5h lunch and three tea breaks. - Avoid gossiping and loitering at work. - Lab at 9 am and leave at 6 pm. Being productive till 11 pm in the lab is a lie people till themselves when their day starts at 1 PM. Everything worth doing can be done with high intensity focus during work hours. And having fun in life is the secret to being productive in a marathon.